IP Library › Patent Application 19018613
Patent Application
App. No. 19/018,613

Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/018,613
Abstract

A composition for treatment of African Swine Fever in swine includes avian-sourced antibodies specific for an African Swine Fever Virus isolate. These antibodies are produced by avian animals immunized against the African Swine Fever Virus isolate and mixed with a protective/reactive matrix obtained from, isolated from, or derived from, non-hyperimmune colostrum.

Claims (11)

1 . A method of treating African Swine Fever in swine in need thereof comprising the steps of administering a combination of:

avian-sourced antibodies specific for an African Swine Fever (ASF) Virus isolate, and

a carrier matrix comprising of non-hyperimmune colostrum.

2 . The composition of claim 1 , wherein the non-hyperimmune colostrum is at least part bovine derived.

3 . The method of claim 1 , wherein the combination further comprises at least one probiotic culture.

4 . The method of claim 1 , wherein the combination further comprises at least one prebiotic.

5 . The method of claim 1 , further comprising a mixture of electrolytes.

6 . The method of claim 1 , further comprising at least one growth factor.

7 . The method of claim 1 , further comprising at least one intestinotrophic growth factor.

8 . The method of claim 1 , wherein the antibodies are sourced from egg yolks from an avian species immunized with a vaccine comprising at least one antigen which initiates production of antibodies directed against one or more ASF-causing pathogens.

9 . The method of claim 1 , further comprising combining a material containing the antibodies with the colostrum in a predetermined ratio by weight, wherein a ratio of the material containing the antibodies is in a range of 20% to 80% by weight, and a corresponding ratio of the material containing the colostrum is in a range of 80% to 20% by weight.